keyboard_arrow_up

Life Science and Chemical Instrumentation Market worth $48.84 Billion by 2019

The report “Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, Spectroscopy, Immunoassay, Microarray, Flow Cytometer, Incubator, Fume Hood, Centrifuge) - Global Forecast to 2019”, this report studies the global life science and chemical instrumentation market over the forecast period of 2014 to 2019. The market is expected to reach $48.84 billion by 2019, at CAGR of 6.9% from 2014 to 2019.


Browse 99 market data tables and 44 figures spread through 280 pages and in-depth TOC on “Life Science and Chemical Instrumentation Market"

http://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-instrumentation-market-38.html

Early buyers will receive 10% customization on this report.

 

On the basis of technology, the global life science and chemical instrumentation market is divided into nine major segments, namely, chromatography (liquid, gas, and others), electrophoresis (gel and capillary), DNA sequencers and amplifiers (thermal cyclers, real-time PCR, and others), lab automation (automated liquid handling, microplate readers, robots, automated storage & retrieval systems, software & informatics, and others), spectroscopy (molecular, atomic, and mass), immunoassay (enzyme, chemiluminescence, radioimmunoassay, fluorescence, and others), microarray (DNA, protein, cell, and tissue), flow cytometry (cell-based, bead-based, and others), and other instruments (centrifuges, laboratory balances, incubators, and fume hoods). The spectroscopy segment accounted for the largest share of the global life science and chemical instrumentation market in 2014.  The DNA sequencers and amplifiers market is poised to grow at the highest CAGR in the next five years, owing to development of technologically advanced cost efficient genome sequencers and amplifiers.

 

The life science and chemical instrumentation market has also been classified on the basis of end user. The major end users of this market include pharmaceutical, biopharmaceutical, and biotechnology companies; clinical research organizations (CROs); research institutions; hospitals, clinics, and diagnostic laboratories; academic institutions; forensic science laboratories; food and agriculture industry; and environmental testing industry; among others.

 

Ask For The PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=38

 

The global life science and chemical instrumentation market is estimated to grow at a CAGR of 6.9% from 2014 to 2019.

 

A number of factors such as growing pharmaceutical R&D investments in emerging countries, increasing food safety concerns, availability of public and private funding for life science research studies, technological advancements in analytical instruments, and stringent drug development regulations in developed countries are propelling the growth of the global life science and chemical instrumentation market. However, high cost of technologically advanced instruments, scarcity of skilled professionals, and presence of alternative technologies are some of the major factors restraining the growth of this market. Nonetheless, increasing number of metabolomics and proteomics research studies, burgeoning growth of biosimilars market, rising environmental safety concerns, and growing pharmaceutical industry in India and china are offering new growth opportunities for the players engaged in the development and manufacturing of life science and chemical instrumentations.

 

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. In 2014, the global life science and chemical instrumentation market was dominated by North America. The large market share of this region is attributed to the high volume of drug discovery and life science research studies, high adoption rate of novel technologies, stringent drug development regulations, and availability of huge funding for research studies in North American countries. The Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2019. This is primarily due to the factors such as strategic expansion by key market players in emerging Asian countries; growing pharmaceutical industry in India and China; rising government investment in biomedical industry in Singapore and China; and increasing outsourcing of R&D activities by global pharma companies to developing Asian countries due to cost benefits.

 

Get The Sample Copy Of This Report: http://www.marketsandmarkets.com/requestsample.asp?id=38

 

New product launches is the key growth strategy adopted by the major players to develop their position in the global life science and chemical instrumentation market. Moreover, strategies such as partnerships, agreements, collaborations, expansions, and acquisitions were also adopted by a significant number of market players to strengthen their product portfolio and expand their customer base in this market.

 

Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S.),  Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.) are some of the key players operating in the global life science and chemical instrumentation market.

 

About MarketsandMarkets:

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

 

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

 

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

 

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

 

Contact:
Mr. Rohan

Unit No. 802, 8th Floor, 

Tower - 7, Magarpatta City SEZ,

Hadapsar, Pune – 411013, 

Maharashtra, India.

Tel: +1-888-6006-441.
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets